Michal Hawranek

Michal Hawranek

Interventional cardiologist / Cardiologist
Silesian Center for Heart Diseases - Zabrze, Poland

Latest contributions

Patients with degenerated aortic bioprothesis - Every case is different

22 May 2025 – From EuroPCR 2025

Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...

Patients with degenerated aortic bioprothesis - Every case is different

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

21 May 2025 – From EuroPCR 2025

This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

Complex PCI for severely calcified, uncrossable RCA lesion

07 Apr 2025

A 72-year-old male patient with stable coronary artery disease was admitted for recurrence of angina (CCS II/III). Coronary angiography revealed significant stenosis in the mid-portion of RCA. Ad hoc PCI of RCA was unsuccessful due to an uncrossable lesion...

Michal Hawranek

Author

Michal Hawranek
Lukasz Pyka

Author

Lukasz Pyka

Left main: presentation and diagnosis

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the presentation and diagnosis of left main coronary artery disease. It covers various case presentations and discussions, including isolated aortitis with critical coronary ostial stenosis due to Takayasu arteritis, acute left main occlusion, and critically...

Left main: presentation and diagnosis

Restoring vessel physiology drives outcomes - The Bioadaptor experience

16 May 2024 – From EuroPCR 2024

Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...

Restoring vessel physiology drives outcomes - The Bioadaptor experience

Calcified coronary lesions: procedural techniques

15 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on procedural techniques for the management of calcified coronary lesions. It will feature various complex cases, including in-stent shave and debulk, damned coronary nodules, rotatripsy burring before the shock, protected high-risk PCI of a heavily calcified...

Calcified coronary lesions: procedural techniques

It's not all about the anatomy - When physiology matters!

14 May 2024 – From EuroPCR 2024

This session, in collaboration with various international cardiology societies, emphasizes the importance of physiology-guided interventions in complex multivessel disease. It presents three cases demonstrating the use of CTCA-derived cFFR, pressure wire assessment in bifurcation PCI, and angio-based FFR to guide treatment decisions. The discussions highlight how...

It's not all about the anatomy - When physiology matters!

TAVI - Durability and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...

TAVI - Durability and long-term outcomes

How to treat coronary aneurysm

18 May 2023 – From EuroPCR 2023

Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...

How to treat coronary aneurysm

TAVI in heavily calcified aortic disease - How to choose the proper treatment strategy?

18 May 2023 – From EuroPCR 2023

Consult this session if you want to outline how the heart team should individualise treatment for patients with complex calcified aortic stenosis, to review steps for TAVI in complex calcified aortic stenosis, and to learn about device selection and implantation techniques in calcified anatomies.

TAVI in heavily calcified aortic disease

Euro4C Editorial Team

22 Oct 2021

Euro4C stands for the Cardiac Care of Calcified and Complex patients. The mission of the Euro4C Editorial Team is to present and/or select a series of educational cases on the management of complex patients with calcified CAD in a clearly structured way...

Advanced TAVI: challenges and complexities in TAVI 2019 in high-risk patients

24 May 2019 – From EuroPCR 2019

Consult this session on advanced TAVI to discover all about the challenges and complexities in TAVI 2019 in high-risk patients with difficult anatomies, and how to prevent and overcome them.

Advanced TAVI: challenges and complexities in TAVI 2019 in high-risk patients